Pharma BD Deal Intelligence
Ranks computed across 828 graded deals (Critic + Outcome Score both present).
Chemical Bank committed $1.2B to finance the hostile takeover bid, reflecting Wall Street confidence in AHP's ability to extract value from Cyanamid's…
FTC reviews American Home Products Corporation's acquisition of American Cyanamid Company.
American Cyanamid's rise and fall illustrates the risks of conglomerate dismemberment — AHP's $9.5B hostile bid targeted Cyanamid's pharma crown jewels while…
Source summaries from our enrichment pipeline; follow links for originals.
All 9 sources with sentiment breakdown →
American Home Products acquired American Cyanamid for approximately $9.7 billion in cash ($95/share), then the second-largest industrial acquisition in U.S. history. The deal gave AHP access to Cyanamid's strong agricultural chemicals and pharmaceutical pipeline, including the Lederle Laboratories division.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| American Home Products Corporation / American Cyanamid Company (this deal) | 1994 | $9.7B | 83 |
| American Home Products Corporation / BASF AG (Cyanamid agricultural divestiture) | 2000 | $3.8B | 78 |
| AstraZeneca PLC / Daiichi Sankyo Company, Limited | 2019 | $6.9B | 100 |
| Novartis AG / Endocyte, Inc. | 2018 | $2.1B | 96 |
| Astellas Pharma Inc. / Seagen Inc. | 2009 | $4.5B | 95 |
| Bristol-Myers Squibb Company / Medarex Inc. | 2009 | $2.4B | 92 |
| Servier / Agios Pharmaceuticals (oncology) | 2020 | $2.0B | 91 |
← Browse all deals · How we score deals
More: 1994 deals · Oncology deals